Indian pharmaceutical company Panacea Biotec recently announced
that it had secured a patent for the production of its popular
non-steroidal anti-inflammatory drug (NSAID) Willgo, containing the
chemical compound nimesulide. The medication, which Panacea
introduced in 2004, relieves the chronic joint pain that is a
result of osteoarthritis, according to the company. Furthermore,
the medication is classified as Extended Release, which
means that it is designed to combat the many symptoms of
osteoarthritic joints over an extended period of time-- symptoms
that include stiffness, tenderness, swelling, as well as the
aforementioned joint pain. Panacea touts its ability to improve
functional mobility for the osteoarthritis patients who
Nonsteroidal anti inflammatory drugs (NSAIDs) are commonly used to treat the pain and swelling of arthritis and other musculoskeletal conditions. NSAIDs come in prescription form (e.g. Celebrex, Mobic) and over the counter (e.g. aspirin, ibuprofen). Studies have shown that about 30% of people with some form of arthritis use over-the-counter NSAIDs on a daily basis. Many other people take a combination of prescription and OTC NSAIDs daily to manage their pain, even though long term NSAID use can lead to gastrointestinal problems and overuse can lead to drug toxicity. A recent study published in the February issue of Arthritis & Rheumatism found an association between dual use of NSAIDs and poorer health status. The study defined dual use as taking two NSAIDS, either prescription or OTC, at least twice a week during the month before the study survey was conducted. 182 patients in a managed care organization participated in the study. Of these patients, half had either rheumatoi...
Health care professionals depend on good sources of information to keep up-to-date on evidence-based medicine. One of the most reliable publications comes from the Cochrane Collaboration . Everyone pays attention when they publish a study. The Cochrane Collaboration is a group of over 11,500 volunteers who systematically review all relevant randomized controlled trials on a specific topic. The people in the group are located in more than 90 countries. They also study the results of non-randomized, observational studies. The results of these systematic reviews are published in the Cochrane Library. In this study, the use of nonsteroidal antiinflammatory drugs (NSAIDs) for low back pain (LBP) was reviewed. The goals were to 1) look for effects of NSAIDs and 2) find out which type of NSAID works the best. Specifically, COX-2 inhibiting NSAIDs were considered. These drugs have a lower risk of gastrointestinal side effects. For this reason, they have recently become more popular than the trad...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.